---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-021282"
form_type: "8-K"
ticker: "PALX"
cik: "0001938569"
company_name: "Palomino Laboratories Inc."
filed_at: "2026-05-05T23:59:59+00:00"
generated_at: "2026-05-14T23:34:39.694061+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Palomino Labs completes $1.88M second closing of private placement; total proceeds $16.98M

## Summary
- Second closing on Apr 30, 2026: 470,000 shares at $4.00/share, gross proceeds $1,880,000.
- Combined with initial closing (3,773,853 shares at $4.00), total shares 4,243,853 and aggregate proceeds $16,975,412.
- Laidlaw & Company received cash fees (10% of introduced proceeds, 5% of company-introduced) and expense reimbursement.
- Placement agent also received 374,761 warrants at $4.80 exercise price (120% of offering price), 5-year term, cash exercise.
- Offering exempt under Section 4(a)(2) and Rule 506 of the Securities Act to accredited investors.

## SEC filing metadata
- accession: 0001493152-26-021282
- form_type: 8-K
- ticker: PALX
- cik: 0001938569
- company_name: Palomino Laboratories Inc.
- filed_at: 2026-05-05T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- confidence: high
- sec_items: 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1938569/000149315226021282/0001493152-26-021282-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1938569/000149315226021282/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-021282
- JSON: https://secwatch.observer/filing/0001493152-26-021282.json
- Plain text: https://secwatch.observer/filing/0001493152-26-021282.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.